About Cannaceutical Science, Inc.
CSI is a full-service contract research/manufacturing organization (CRO/CMO) specializing in the formulation, process development, and scale-up of cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), and full spectrum extract, from industrial hemp. We produce products in both powder and liquid form.
In 2011, we began a quest to formulate a highly bioavailable, water soluble version of CBD and after some trial and error, we got it right. Over the past 7 years, we’ve refined our process and formulations while applying our IP to create a number of finished products for our clients. Our clients range from Doctors to entrepreneurs all looking for the same thing – the best CBD products on the market.
CSI is the first research organization to offer
BioSolCBDTM – A WATER SOLUBLE POWDER THAT UTILIZES CANNABIDIOL, IN ITS AMORPHOUS PHASE, WHILE CONTAINED IN A MICRO-ENCAPSULATION OF A NANO-EMULSION.
This structure increases the active’s bioavailable, while allowing manufactures to incorporate the powder into many delivery/packaging forms and retain stability of the CBD.
Our Technology
Our technology makes it possible to create unique particles possessing specific controlled release patterns and properties. Our sustained release formulations allow for a reduction in dosage, a reduction of concentration peaks and offers unattainable delivery methods and molecular characteristics. We also offer liquid based formulations used in bottled water, nasal sprays, pain sprays, and tinctures.